Genomics BioSci & Tech. Co.,Ltd. (TPEX: 4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.20
+0.10 (0.52%)
Dec 31, 2024, 3:00 PM CST

Genomics BioSci & Tech. Co.,Ltd. Company Description

Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services.

The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening services.

Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan.

Genomics BioSci & Tech. Co.,Ltd.
Country Taiwan
Founded 2001
Industry Biotechnology
Sector Healthcare
CEO Kevin Chiang

Contact Details

Address:
No.100, Xintai 5th Road
New Taipei City
Taiwan
Phone 886 2 2696 1658
Website genomics.com.tw

Stock Details

Ticker Symbol 4195
Exchange Taipei Exchange
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004195003
SIC Code 2836

Key Executives

Name Position
Kevin Chiang Chief Executive Officer
De-Yuan Zhou Founder